JetBlue, the current leader, said it plans 154 summer departures, while American has not released its summer schedule. JetBlue spokesman Philip Stewart said the carrier will maintain its seat advantage into the summer. August schedules show JetBlue with 631,027 seats and Delta with 615,2307 seats. “We will offer more seats (as) a result of all mainline aircraft,” he said. Many Delta domestic flights are on regional aircraft operated by Delta Connection affiliates. What Delta is doing in Boston is the same thing it did in Seattle, where – starting in 2014 - it built a domestic hub largely on the strength of international service that was superior to what incumbent carrier Alaska could provide. Now Delta sees a path to becoming the number one carrier at Logan as it continues to grow, particularly in international flights. anchor carrier for transatlantic, so I think there’s a great opportunity for us.” “We always did very well domestically in Boston, but internationally it’s mostly foreign flags flying into Boston,” Joe Esposito, Delta senior vice president for network planning, told The Points Guy.
He said that Delta will eventually serve eight of the top 10 transatlantic destinations from Boston – “That’s a pretty good portfolio to go to market with” - and that 25% of the international passengers will make domestic connections.Īiding Delta in Boston is joint-venture partners Air France-KLM, which strengthens its transatlantic position at Logan. KLM operates three weekly departures to Amsterdam, where it offers connections throughout Europe. KLM CEO Pieter Elbers told The Points Guy that 15% to 20% of KLM’s Boston passengers connect via Delta. “We do best to Delta strongholds,” he said during an interview at the IATA conference in Boston. Boston is a strong market, he added with leisure travelers as well as business travel involved in universities and corporations including pharmaceutical companies. Esposito of Delta said Boston provides “a high level of business traffic (that is) well diversified with education, high tech, pharmaceuticals and other corporations.
0 kommentar(er)
